|
|||||
|
|
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis |
|
| Institution: | 1. Division of Gastroenterology, University of California, San Diego, La Jolla, California;3. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York;4. Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota;5. Division of Gastroenterology, Montefiore Medical Center, Bronx, New York;7. Division of Gastroenterology, North Shore University Hospital, Manhasset, New York;12. Division of Gastroenterology, New York University, New York, New York;8. Division of Gastroenterology, Indiana University, Indianapolis, Indiana;9. Division of Gastroenterology, Lenox Hill Hospital, New York, New York;71. Takeda Pharmaceuticals USA, Deerfield, Illinois;123. Division of Gastroenterology, University of Western Ontario, London, Ontario, Canada;84. Robarts Clinical Trials, London, Ontario, Canada |
| Abstract: | |
| Keywords: | Prognostic Factor Response to Treatment Personalized Medicine Biologic CDST"} {"#name":"keyword" "$":{"id":"kwrd0035"} "$$":[{"#name":"text" "_":"clinical decision support tool CI"} {"#name":"keyword" "$":{"id":"kwrd0045"} "$$":[{"#name":"text" "_":"confidence interval CSFREM"} {"#name":"keyword" "$":{"id":"kwrd0055"} "$$":[{"#name":"text" "_":"corticosteroid-free remission ITT"} {"#name":"keyword" "$":{"id":"kwrd0065"} "$$":[{"#name":"text" "_":"intention to treat OR"} {"#name":"keyword" "$":{"id":"kwrd0075"} "$$":[{"#name":"text" "_":"odds ratio TNF"} {"#name":"keyword" "$":{"id":"kwrd0085"} "$$":[{"#name":"text" "_":"tumor necrosis factor UC"} {"#name":"keyword" "$":{"id":"kwrd0095"} "$$":[{"#name":"text" "_":"ulcerative colitis VDZ"} {"#name":"keyword" "$":{"id":"kwrd0105"} "$$":[{"#name":"text" "_":"vedolizumab |
| 本文献已被 ScienceDirect 等数据库收录！ | |